 |
| Ex vivo scans of hearts from fibrotic (left) and control mice which were administered a unique fluorescent peptide that targets collagen type I. A striking enhancement of the damaged heart ventricles is observed. Image: Figure 5 in study |
Dr Be'eri Niego (CIA), Dr Karen Alt (CIB) and Professor Christoph Hagemeyer (CIC) are recipients of a Heart Foundation Vanguard grant announced 6 October. The grant is for $150,000 across two years.
Dr Alt said, "In this project, we aim to develop new peptides, which tightly bind various types of collagen and enable the delivery of imaging contrast agents to the affected heart. This clever approach, also termed 'Molecular Imaging', allows more sensitive imaging and earlier diagnosis of heart conditions."
See all 2022 Vanguard grant recipients at the A+ precinct here.
No comments:
Post a Comment
Thankyou for your comment. We moderate all messages and may take a little time to review your comment. Please email inquiries to ccs.comms@monash.edu.